Russell Investments Group Ltd. boosted its stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN) by 68.3% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 273,987 shares of the business services provider’s stock after buying an additional 111,178 shares during the period. Russell Investments Group Ltd. owned 0.75% of Cross Country Healthcare worth $3,538,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CCRN. Ranger Investment Management L.P. boosted its position in shares of Cross Country Healthcare by 27.3% in the first quarter. Ranger Investment Management L.P. now owns 100,810 shares of the business services provider’s stock valued at $1,448,000 after buying an additional 21,590 shares during the last quarter. Bank of America Corp DE boosted its position in shares of Cross Country Healthcare by 126.6% in the first quarter. Bank of America Corp DE now owns 72,753 shares of the business services provider’s stock valued at $1,045,000 after buying an additional 40,650 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its position in shares of Cross Country Healthcare by 1.0% in the first quarter. Schwab Charles Investment Management Inc. now owns 62,315 shares of the business services provider’s stock valued at $895,000 after buying an additional 600 shares during the last quarter. Lucus Advisors LLC purchased a new position in shares of Cross Country Healthcare during the first quarter valued at approximately $413,000. Finally, Globeflex Capital L P purchased a new position in shares of Cross Country Healthcare during the first quarter valued at approximately $104,000. Institutional investors own 91.48% of the company’s stock.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) traded down 0.16% during mid-day trading on Monday, hitting $12.17. 28,332 shares of the stock were exchanged. The stock has a market capitalization of $444.13 million, a P/E ratio of 44.91 and a beta of 0.83. The firm has a 50-day moving average price of $12.30 and a 200-day moving average price of $13.23. Cross Country Healthcare, Inc. has a 12-month low of $10.88 and a 12-month high of $16.38.

Cross Country Healthcare (NASDAQ:CCRN) last announced its earnings results on Wednesday, August 2nd. The business services provider reported $0.16 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.09 by $0.07. The company had revenue of $209.31 million for the quarter, compared to analysts’ expectations of $209.92 million. Cross Country Healthcare had a return on equity of 12.78% and a net margin of 1.06%. Cross Country Healthcare’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.16 earnings per share. Equities analysts predict that Cross Country Healthcare, Inc. will post $0.61 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/08/28/cross-country-healthcare-inc-ccrn-stake-increased-by-russell-investments-group-ltd.html.

Several research analysts have commented on the stock. Zacks Investment Research cut shares of Cross Country Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Benchmark Co. reiterated a “buy” rating and issued a $17.00 target price (down from $18.00) on shares of Cross Country Healthcare in a report on Wednesday, August 9th. BidaskClub cut shares of Cross Country Healthcare from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. UBS AG reiterated a “buy” rating and issued a $15.00 target price (down from $16.50) on shares of Cross Country Healthcare in a report on Wednesday, June 14th. Finally, BMO Capital Markets decreased their target price on shares of Cross Country Healthcare from $18.00 to $15.00 and set an “outperform” rating for the company in a report on Monday, May 15th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company’s stock. Cross Country Healthcare presently has an average rating of “Buy” and a consensus target price of $15.64.

In related news, insider William J. Grubbs sold 49,113 shares of Cross Country Healthcare stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $12.16, for a total transaction of $597,214.08. Following the transaction, the insider now owns 395,188 shares of the company’s stock, valued at $4,805,486.08. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 4.20% of the stock is owned by insiders.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Want to see what other hedge funds are holding CCRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cross Country Healthcare, Inc. (NASDAQ:CCRN).

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Stock Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related stocks with our FREE daily email newsletter.